B.1. TREATMENT REQUIREMENTS, LIMITATIONS AND MONITORING
LASP
Reissuance, Quitman WPCP, GAJ020022 --GA-EPD
30 August 2018
smaller
PDF
![[prev]](/gifs/arrow.plain.left.gif){kind=icon}
![[index]](/gifs/arrow.plain.up.gif){kind=icon}
![[next]](/gifs/arrow.plain.right.gif){kind=icon}
